Lumicell
Lumicell is specializing in the field of image-guided cancer surgery. The company's technology illuminates cancer cells in the tumor cavity, enabling physicians to take action in real-time to improve patient outcomes. The company's lead product, consisting of a fluorescent optical contrast agent and a handheld illumination device, is currently under clinical investigation in patients undergoing breast cancer surgery. A planned pivotal study aims to evaluate the ability of the technology to reduce positive margin rates and reduce repeat surgeries while sparing healthy tissue. Lumicell technology is also being investigated in colorectal cancer, Barrett’s Esophagus, pancreatic cancer, and brain metastases. In clinical studies to date, no cancer has been missed and the safety profile of the optical contrast agent has been demonstrated. Lumicell was founded in 2008 and is based in Newton, MA, USA.
Domain
lumicell.com
Country
United StatesIndustry
BiotechnologyEmployees
51-100
Last Funding
$198.1M
Founded
2007
Tech Stack (24 technologies)
Frequently Asked Questions
What technologies does Lumicell use?+
Lumicell uses 24 technologies including Elementor, Google Analytics, Google Tag Manager.
What industry is Lumicell in?+
Lumicell operates in the Biotechnology industry.
Where is Lumicell based?+
Lumicell is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026